Research and development of new treatments for eye diseases, particularly retinitis pigmentosa, are given high priority by the Retina Industry. Retina care Michigan is a fully staffed study team that looks for treatment options for their patients. Retina care Michigan collaborates with a fully staffed Ophthalmology department to identify and test new therapies for all eye diseases. Both scientific types of research includes highly trained doctors for the treatment and prevention of retinal degeneration as well as for the prevention and treatment of cataracts and other eye diseases.
The practice has other components that add another dimension to their understanding of the retinal disease and patient care. Dr. Kaushal also deals with retina surgical issues, including cataract, retinitis pigmentosa, macular degeneration, and retinal detachment. His research focuses on treating patients with inherited retinal disorders and chronic infectious conditions such as HIV / AIDS, hepatitis C, diabetes, cancer, glaucoma, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and other eye disorders.
Although Argus II is an epiretinal implant, i.e. it is located directly in the eye, other devices under development, such as those in Reutlingen, Germany, are intended to be mounted in and around the retina. They create semiconductor devices that turn light into electricity and sense the light that goes directly through the eyes. These subretinal implants will activate the cells that are responsible for processing signals normally implanted into the retina. The researchers hope to maintain the signal production of the healthy retina by stimulating higher-altitude cells.
If too many retinal ganglion cells die these implants will help. This is a chronic eye condition that primarily affects photoreceptor cells like retinitis pigmentosa (AMD) but can also cause cells to leave the activated cells when activated, as is the case with advanced diabetic retinopathy and glaucoma. For those with a comparatively limited number of retina cells, such as those that remain in retinal operation, the alternative bionic solution is more applicable. Near-Infrared light supplies power to suit the implants.
Entry to healthcare is a rising obstacle for AMD patients, who also struggle with issues of near blindness and transportation. The problem of caring for millions of additional patients is likely to be compounded by enhanced diagnostic techniques more commonly used by ophthalmologists and optometrists, which could lead to the identification of more disease pathologies. Dr. Aker offers mini-retinal fellowships to generals and ophthalmologists that can help them heal retinal problems and help them create new therapies for AMD and other retinal diseases. Most generalists have already started retinal care and refer patients to specialist treatment when they need to.
Humayun warns that such procedures are still several years away from clinical use, as the approval process has not yet passed stem cell therapies for retinal diseases. Such and similar methods may address the need to replace missing neurons at an early stage of basic research and open the door to treatment for a number of eye diseases. Reptiles and other fish can regenerate the retinal neurons, and birds too can regenerate. In humans mature neurons divide and rebuild, making vision restore particularly difficult.
In recent years, the environment for treating retinal disorders has changed significantly, with the introduction of new medications linked to aging and aging for wet macular degeneration. Treatments such as aflibercept and ranibizumab were accepted in the United States and applied to the treatment of retinitis pigmentosa, glaucoma, diabetic reticulopathy, and diabetic cataracts. There are more than 1,000 experimental treatments for these diseases currently in clinical trials. With the continuing dedication of the National Institutes of Health (NIH) and the American Academy of Ophthalmology, ophthalmologists provide more proof in all facets of this research that substantial progress is being made in maintaining vision in the aging populations.